Argentina
Introduction: patients receiving treatment with Prasugrel for the prevention of acute coronary artery disease may suffer a hemorrhagic stroke as a complication, this being one of the most serious complications and with the highest mortality associated with the use of antiplatelet agents. Objective: to analyze the relationship between antiplatelet therapy with Prasugrel and the occurrence of hemorrhagic stroke.Methods: search of information in the Scopus, Web of Science and SciELO databases on hemorrhagic encephalic vascular accidents during the use of Prasugrel. Results: a total of 50 articles were found that met the inclusion and exclusion criteria, 3 of which were used for this study. Conclusion: risk factors such as arterial hypertension, diabetes, advanced age predisposes patients to hemorrhagic stroke during treatment with Prasugrel
© 2001-2026 Fundación Dialnet · Todos los derechos reservados